BRS is a Game Changer for PAD Treatment Trial

Monday, March 9, 2026

11:21 AM - 11:29 AM EST

Location: International Ballroom West

Speaker(s)

Sahil A. Parikh, MD, FSCAI

Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States

Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Advanced NanoTherapies: Stock Options [in privately held companies] (Ongoing); AVS: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Encompass vascular: Stock Options [in privately held companies] (Ongoing); Fastwave: Grant/Research Support (Ongoing); Inari/Stryker: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Grant/Research Support (Ongoing); Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); R3 Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Sahil A. Parikh, MD, FSCAI: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Advanced NanoTherapies: Stock Options [in privately held companies] (Ongoing); AVS: Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cagent Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Encompass vascular: Stock Options [in privately held companies] (Ongoing); Fastwave: Grant/Research Support (Ongoing); Inari/Stryker: Consulting Fees (e.g., advisory boards) (Ongoing); Medinol: Grant/Research Support (Ongoing); Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); R3 Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing)